ENDRA Life Sciences Inc. (NDRA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.12M | -1.61M | -1.16M | -1.11M | -1.29M | -1.52M | -1.66M | -2.08M | -2.14M | -2.17M | -2.6M | -2.27M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 13.42% | -6.33% | 29.76% | 46.54% | 39.69% | 30.3% | 36.23% | 8.17% | 14.46% | 29.6% | 19.96% | 31.98% |
| Net Income | -1.31M | -3.17M | -1.6M | -1.23M | -1.04M | -4.15M | -2.35M | -2.23M | -2.78M | -1.46M | -3.1M | -2.56M |
| Depreciation & Amortization | 39.72K | 39.53K | 39.39K | 32.79K | 45.58K | 46.36K | 54.01K | 50.12K | 55.68K | 61.25K | 70.45K | 72.71K |
| Stock-Based Compensation | 574.45K | 12.88K | 144.72K | 88.76K | 83.05K | 104.68K | -36.85K | 186.59K | 317.5K | 250.56K | 252.74K | 255.85K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.65M | -262.84K | -227.75K |
| Other Non-Cash Items | -861.96K | 1.54M | 267.27K | -62.11K | -408.56K | 2.27M | 910.6K | -138.05K | 151.54K | 1.81M | 262.84K | 227.75K |
| Working Capital Changes | 439.58K | -33.84K | -19.43K | 52.76K | 23.13K | 211.13K | -230.91K | 47.18K | 106.67K | -1.19M | 178.89K | -40.03K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -195.81K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 329.48K | 0 | 138.05K | -231.79K | -3.28K | 0 | -22.28K |
| Change in Payables | 79.91K | -49.94K | 223.09K | 8.73K | -68.6K | -124.77K | -540.78K | 128.97K | 337.71K | -1.27M | 130.8K | 195.81K |
| Cash from Investing | 450K | -3M | 0 | 0 | -17.28K | 0 | 0 | 11K | -23.8K | 2.28K | 0 | 0 |
| Capital Expenditures | 0 | -3M | 0 | 0 | -17.28K | 0 | 0 | 11K | -27K | -6.88K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.16K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 450K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.2K | 9 | 0 | 0 |
| Cash from Financing | 263.75K | 4.58M | 149.47K | 857.41K | 145.8K | 0 | 1.68K | 7.34M | 468.9K | 1.67M | 1.11M | 4.73M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28.48K | 0 | 0 | 0 |
| Equity Issued (Net) | 263.75K | 4.58M | 149.47K | 857.41K | 145.8K | 0 | 1.68K | 728.5K | 419.97K | 656.81K | 1.11M | 4.71M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -840 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.61M | 77.42K | 1.02M | 0 | 20.05K |
| Net Change in Cash | -405.9K | -31.67K | -1.01M | -256.3K | -1.16M | -1.52M | -1.66M | 5.27M | -1.7M | -500.63K | -1.48M | 2.46M |
| Free Cash Flow | -1.12M | -4.61M | -1.16M | -1.11M | -1.31M | -1.52M | -1.66M | -2.07M | -2.17M | -2.18M | -2.6M | -2.27M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 14.56% | -204.26% | 29.76% | 46.26% | 39.65% | 30.52% | 36.23% | 8.65% | 14.31% | 30.24% | 20.32% | 33.17% |
| FCF per Share | -0.93 | -5.86 | -1.53 | -1.55 | -2.35 | -2.82 | -1.48 | -1.21 | -1.27 | -1.28 | -1.52 | -1.33 |
| FCF Conversion (FCF/Net Income) | 0.85x | 0.51x | 0.73x | 0.91x | 1.25x | 0.37x | 0.70x | 0.93x | 0.77x | 1.49x | 0.84x | 0.89x |
| Interest Paid | 0 | -28.13K | -26.18K | 54.31K | 0 | 8.7K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |